The same group showed, using paired isogenic colon cancer cell lines, that metformin selectively inhibited p53 negative tumor cell growth in vivo[3] With the panel of cultured breast cancer cell lines used in our experiments, we have not observed any correlation between either cell cycle arrest or cell survival and p53 expression. The gene discussed is TP53; the disease is neoplasm.